Johns Hopkins Hospital
Baltimore, Maryland, 21205, United States
NCT Number: NCT01091597
Curative catheter ablation has been established as an effective therapeutic option for atrial fibrillation (AF) that is resistant to pharmacologic rhythm or rate control. However, standard ablative approaches targeting the pulmonary veins (PVs) are associated with a success rate as low as 40%. In a recent study, Kumagai et al. described a new approach of catheter ablation of AF isolating the posterior left atrium including all PVs (called Box Isolation). In Kumagai's study, 46 patients with symptomatic AF underwent box isolation. At 6 months follow up, 43 of 46 patients (93%) were arrhythmia free without antiarrhythmic drugs, with a single procedure success rate of 87% (40/46). This study provided new evidence supporting the hypothesis that the posterior wall is of high importance for the maintenance of AF. The aim of the investigators study is to determine the efficacy of two different approaches of catheter ablation (Standard PV Isolation vs. Box isolation) for the treatment of chronic AF.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Baltimore, Maryland, 21205, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
usual PV ablation, per above
as above
Time frame: 3 months following ablation
Time frame: 3 months following procedure
Johns Hopkins University
Other
PV Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05306015
Anxiety, Anxiety Disorders
Nanjing, Jiangsu, China
View Trial DetailsNCT06791915
Arrhythmias, Cardiac, Atrial Fibrillation
Kocaeli, Turkey (Türkiye)
View Trial DetailsNCT05610215
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Beijing, China
View Trial DetailsNCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial Details